Apricus Biosciences (APRI) Reports Q3 Loss of $0.19

November 8, 2016 4:40 PM EST
Get Alerts APRI Hot Sheet
Trade APRI Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Apricus Biosciences (NASDAQ: APRI) reported Q3 EPS of ($0.19), versus ($1.00) reported last year. Revenue for the quarter came in at $4.3 million, versus $1.3 million reported last year.

For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment